Astec Lifesciences (BOM:533138) Total Receivables: ₹2,503 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:533138 Astec Lifesciences Ltd BOM:533138
75 GF Score
Price ₹663.25
GF Value ₹1,000.60
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Astec Lifesciences Total Receivables?

Astec Lifesciences BOM:533138 +0.63% 75 Total Receivables is ₹2,503 Mil as of Mar. 2026. GuruFocus rates BOM:533138 with a GF Score™ of 75/100 and a GF Value™ of ₹1,000.60 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Astec Lifesciences's Total Receivables for the quarter that ended in Mar. 2026 was ₹2,503 Mil.

Astec Lifesciences Total Receivables Related Terms

Astec Lifesciences Total Receivables Historical Data

* Premium members only.

The historical data trend for Astec Lifesciences's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astec Lifesciences Total Receivables Chart

Astec Lifesciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,759.62 1,550.73 1,695.85 1,502.80 2,503.13

Astec Lifesciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,502.80 0.00 1,391.42 0.00 2,503.13
BOM:533138
75GF Score
Astec Lifesciences Ltd BOM:533138
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Astec Lifesciences Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of ₹2,503 Mil mean?
Astec Lifesciences (BOM:533138) has a Total Receivables of ₹2,503 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Astec Lifesciences and its competitors.
Is Astec Lifesciences' Total Receivables too high?
Astec Lifesciences' current Total Receivables is ₹2,503 Mil. Overall, Astec Lifesciences has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astec Lifesciences' Total Receivables compare to CTVA and CF?
Astec Lifesciences' Total Receivables of ₹2,503 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for an Agriculture company?
A good Total Receivables depends on the Agriculture industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Astec Lifesciences and its competitors. Astec Lifesciences's current Total Receivables is ₹2,503 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astec Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Astec Lifesciences (BOM:533138) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹1,000.60, compared to a current price of ₹663.25 — trading 33.7% below its estimated fair value. The current Total Receivables is ₹2,503 Mil. Astec Lifesciences' overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Astec Lifesciences (BOM:533138), the current Total Receivables is ₹2,503 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astec Lifesciences (BOM:533138) Overvalued in 2026?

Based on GuruFocus' analysis, Astec Lifesciences stock appears to be undervalued. The current stock price of ₹663.25 is trading 33.7% below its estimated GF Value™ of ₹1,000.60. GuruFocus considers Astec Lifesciences to be Significantly Undervalued.

Key valuation signals for BOM:533138:

  • Total Receivables: ₹2,503 Mil
  • GF Value™: ₹1,000.60 vs. price of ₹663.25 (33.7% below fair value)
  • GF Score™: 75/100 with 4 warning signs

No single metric tells the full story. See the BOM:533138 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Astec Lifesciences Business Description

Other Exchanges ASTEC:India
Address Eastern Express Highway, Godrej One, 3rd Floor, Pirojshanagar, Vikhroli (East), Mumbai, MH, IND, 400 079
Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.
75GF Score

Get the complete analysis for BOM:533138

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹663.25
Price
₹1,000.60
GF Value